This website uses cookies
Read our Privacy policy and Terms of use for more information.
Apr 2, 2026
GLP-1 pill wars heat up, billion-dollar deals fly, and the FDA faces a stacked Q2
Mar 31, 2026
ACIP chaos, Lilly’s $2.75B AI bet, and a biotech policy fight that’s heating up fast.
Mar 19, 2026
This story and more in the March 19, 2026 issue
Mar 17, 2026
This story and more in the March 17, 2026 issue
Mar 12, 2026
This story and more in the March 12, 2026 issue
Mar 10, 2026
This story and more in the March 10, 2026 issue
Mar 5, 2026
This story and more in the March 5, 2026 issue
Mar 3, 2026
This story and more in the March 3, 2026 issue
Feb 26, 2026
This story and more in the February 26, 2026 issue
